Getting Sponsor Oversight Right in Outsourced Clinical Trials
Helping sponsors design effective oversight.
Helping sponsors design effective oversight.
Sponsors increasingly rely on CROs and specialized vendors to execute clinical trials.
Monitoring activities, operational reports, and governance meetings help sponsors stay informed about study progress and key decisions.
But staying informed is not the same as having oversight.
These mechanisms are essential to trial management, yet they do not always give sponsors a clear view of how critical aspects of trial execution are being planned, performed, and overseen across sites, vendors, and processes.
Without a deliberate oversight strategy, important gaps may not become visible until they are harder to address.
Silvertree helps biopharma sponsors design practical oversight approaches and assess how well they operate in outsourced clinical trials.
Our work examines how responsibilities are assigned, how information supports sponsor decisions, and how significant concerns are followed through resolution. The approach reflects the study’s risks and the sponsor’s internal resources.

The right starting point depends on whether you are building an oversight approach, assessing the current model, or examining a specific area of concern.
Establish a practical oversight approach before study execution, with clear responsibilities, governance arrangements, and escalation pathways.
Assess how your current oversight model is designed and operates in practice, identifying strengths and priority areas for improvement.
Examine a specific site, vendor, process, or area of trial conduct where closer review is needed.
From planning through execution, sponsor oversight needs to be deliberate, visible, and accountable.
Silvertree BioLife
SPONSOR OVERSIGHT | CLINICAL TRIAL GOVERNANCE